GOLDMAN SACHS GROUP INC - PARDES BIOSCIENCES INC ownership

PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 60 filers reported holding PARDES BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PARDES BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$1,517,435
+40.8%
838,362
+2.7%
0.00%
Q1 2023$1,077,379
-70.8%
816,196
-62.6%
0.00%
-100.0%
Q4 2022$3,689,951
-65.8%
2,183,403
-62.5%
0.00%
-50.0%
Q3 2022$10,785,000
-17.8%
5,829,671
+36.3%
0.00%
-33.3%
Q2 2022$13,127,000
-13.9%
4,275,914
+102.4%
0.00%0.0%
Q1 2022$15,252,0002,112,4110.00%
Other shareholders
PARDES BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Foresite Capital Opportunity Management V, LLC 5,227,307$85,571,00057.37%
Foresite Capital Management V, LLC 9,400,515$153,886,00037.81%
Lynx1 Capital Management LP 401,593$6,574,0005.74%
FRAZIER MANAGEMENT LLC 2,457,507$40,229,0003.10%
Chescapmanager LLC 971,114$15,897,0002.12%
Monashee Investment Management LLC 500,000$8,185,0002.02%
Arena Capital Advisors, LLC- CA 1,187,449$19,439,0001.79%
Sio Capital Management, LLC 312,438$5,115,0001.54%
Ikarian Capital, LLC 400,000$6,547,0000.98%
DAFNA Capital Management LLC 233,500$3,822,0000.96%
View complete list of PARDES BIOSCIENCES INC shareholders